{"id":"W2005913125","doi":"10.2165/00003495-200565110-00001","title":"Drugs in Development for Hepatitis B","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Lamivudine; Adefovir; Telbivudine; Entecavir; Medicine; HBeAg; Combination therapy; Hepatitis B; Pegylated interferon; Virology; Hepatitis B virus; Pharmacotherapy; Pharmacology; Immunology; Chronic hepatitis; Internal medicine; Virus; Ribavirin; HBsAg","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009392685,0.00102221,0.002201055,0.003830614,0.0002279807,0.000841226,0.000659094,0.0009201628,0.006776831],"category_scores_gemma":[0.001651246,0.000348028,0.0008012314,0.003052183,0.0004426588,0.0009140378,0.0005859626,0.001007684,0.001221193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007146213,"about_ca_system_score_gemma":0.001545935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001527992,"about_ca_topic_score_gemma":0.005674184,"domain_scores_codex":[0.9997093,0.00008234738,0.00007653852,0.0000306957,0.00008109537,0.00002007628],"domain_scores_gemma":[0.998984,0.0005297259,0.0003043376,0.00002191042,0.0001119377,0.00004794823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002588405,0.00007289299,0.0002528327,0.07336334,0.000424936,0.0002033302,0.00004300142,0.0001800801,0.0008653133,0.001111567,0.0207394,0.9024843],"study_design_scores_gemma":[0.0003125723,0.0004802383,0.002436865,0.03291978,0.002527624,0.001572439,0.000106824,0.0000962788,0.0008657535,0.0008507432,0.9578035,0.00002737435],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001240623,0.9986017,0.00006231717,0.0001498364,0.0001092295,0.00001405894,0.00004121699,0.000005661182,0.0008919548],"genre_scores_gemma":[0.0009962753,0.9980405,0.000198477,0.0002138397,0.0000648233,0.00001301236,0.00003067926,8.196778e-7,0.0004416973],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006776831,"threshold_uncertainty_score":0.02267081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05639666729205638,"score_gpt":0.3614276505510224,"score_spread":0.305030983258966,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}